Otros idiomas Bionano Genomics, Inc.

Acciones

BNGO

US09075F3055

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,9493 ^USD	-0,96 %		+25,07 %	-49,77 %

17/04	Bionano Genomics, Inc. y Hangzhou Diagens Biotechnology Co., Ltd. firman una alianza para comercializar el primer análisis citogenético clínico que combina OGM e inteligencia artificial	CI
03/04	Bionano anuncia la publicación de un estudio que demuestra que el OGM identifica aberraciones genéticas en muestras de sarcoma que pueden conducir a un mejor diagnóstico pero que la citogenética clásica pasó por alto	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024	01/05
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference	30/04
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	25/04
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	24/04
Bionano Genomics, Hangzhou Diagens Biotechnology to Commercialize Cytogenetic Workflow for Reproductive Health	17/04
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence	17/04
Bionano Genomics, Inc. and Hangzhou Diagens Biotechnology Co., Ltd. Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines OGM and Artificial Intelligence	17/04
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing	11/04
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	04/04
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics	03/04
Bionano Announces Publication Showing That Ogm Identifies Genetic Aberrations in Sarcoma Samples That May Lead to Improved Diagnosis But Were Missed by Classical Cytogenetics	03/04
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting	02/04
Bionano Genomics, Inc. Announces Nine Poster Presentations and Introduces New High Throughput Stratys System at American Association for Cancer Research Annual Meeting	02/04
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	19/03
Bionano Genomics, Inc. Announces Publication of Breast Cancer Study Showing the Number of SVs Detected with OGM May be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	19/03
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System	07/03
Bionano Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Bionano Genomics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024	05/03
Bionano Genomics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	05/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Bionano Genomics, Inc.

Acciones

BNGO

US09075F3055

Otros idiomas

Filtros